NM_000020.3:c.143G>A
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000020.3(ACVRL1):c.143G>A(p.Gly48Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G48V) has been classified as Pathogenic.
Frequency
Consequence
NM_000020.3 missense
Scores
Clinical Significance
Conservation
Publications
- telangiectasia, hereditary hemorrhagic, type 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp
- hereditary hemorrhagic telangiectasiaInheritance: AR, AD Classification: SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ACVRL1 | NM_000020.3 | c.143G>A | p.Gly48Glu | missense_variant | Exon 3 of 10 | ENST00000388922.9 | NP_000011.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ACVRL1 | ENST00000388922.9 | c.143G>A | p.Gly48Glu | missense_variant | Exon 3 of 10 | 1 | NM_000020.3 | ENSP00000373574.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Telangiectasia, hereditary hemorrhagic, type 2 Pathogenic:1Other:1
This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 48 of the ACVRL1 protein (p.Gly48Glu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with hereditary hemorrhagic telangiectasia (PMID: 17786384, 21158752, 24603890; internal data). ClinVar contains an entry for this variant (Variation ID: 156350). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt ACVRL1 protein function with a positive predictive value of 95%. This variant disrupts the p.Gly48 amino acid residue in ACVRL1. Other variant(s) that disrupt this residue have been observed in individuals with ACVRL1-related conditions (PMID: 15024723, 15521985, 17786384, 21158752, 24603890), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. -
- -
Cardiovascular phenotype Pathogenic:1
The p.G48E variant (also known as c.143G>A), located in coding exon 2 of the ACVRL1 gene, results from a G to A substitution at nucleotide position 143. The glycine at codon 48 is replaced by glutamic acid, an amino acid with similar properties. This variant has been detected in individuals from hereditary hemorrhagic telangiectasia (HHT) cohorts, several of whom were indicated as having epistaxis, telangiectasia, and positive family history (Brusgaard K et al. Clin Genet, 2004 Dec;66:556-61; Olivieri C et al. J Hum Genet, 2007 Sep;52:820-829; McDonald J et al. Clin Genet, 2011 Apr;79:335-44; Tørring PM et al. PLoS One, 2014 Mar;9:e90272). Based on internal structural analysis, this alteration is predicted to be structurally deleterious (Townson SA et al. J Biol Chem. 2012 Aug;287(33):27313-25). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at